Does OSELTAMIVIR Cause Hyperlipidaemia? 56 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 56 reports of Hyperlipidaemia have been filed in association with OSELTAMIVIR (oseltamavir phosphate). This represents 0.5% of all adverse event reports for OSELTAMIVIR.
56
Reports of Hyperlipidaemia with OSELTAMIVIR
0.5%
of all OSELTAMIVIR reports
55
Deaths
50
Hospitalizations
How Dangerous Is Hyperlipidaemia From OSELTAMIVIR?
Of the 56 reports, 55 (98.2%) resulted in death, 50 (89.3%) required hospitalization, and 49 (87.5%) were considered life-threatening.
Is Hyperlipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OSELTAMIVIR. However, 56 reports have been filed with the FAERS database.
What Other Side Effects Does OSELTAMIVIR Cause?
Vomiting (1,561)
Off label use (1,538)
Nausea (1,055)
No adverse event (810)
Drug ineffective (688)
Dyspnoea (582)
Diarrhoea (553)
Hallucination (502)
Influenza (443)
Rash (439)
What Other Drugs Cause Hyperlipidaemia?
ALENDRONATE (511)
AMLODIPINE (226)
DENOSUMAB (204)
SITAGLIPTIN (186)
METHOTREXATE (184)
ROSUVASTATIN (179)
PREDNISONE (169)
FINASTERIDE (145)
MYCOPHENOLATE MOFETIL (141)
ASPIRIN (138)
Which OSELTAMIVIR Alternatives Have Lower Hyperlipidaemia Risk?
OSELTAMIVIR vs OSILODROSTAT
OSELTAMIVIR vs OSIMERTINIB
OSELTAMIVIR vs OSPEMIFENE
OSELTAMIVIR vs OSPHENA
OSELTAMIVIR vs OVINE DIGOXIN IMMUNE FAB